「PTEN is a predictive biomarker of trastuzumab resistance and prognostic factor in HER2-overexpressing gastroesophageal adenocarcinoma」の関連論文
-
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
-
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
-
Paraneoplastic Pemphigus Mimicking Toxic Epidermal Necrolysis Associated with Follicular Lymphoma: Possible Pathological Role of CD8 T Cells.
-
Dysbiosis of the salivary microbiota in pediatric-onset primary sclerosing cholangitis and its potential as a biomarker
-
Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer
-
A randomized controlled study comparing a vessel sealing system with the conventional technique in axillary lymph node dissection for primary breast cancer (本文)
-
Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
-
Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
-
The baseline recurrence risk of patients with intermediate-risk cervical cancer.
-
Proton radiotherapy as a treatment strategy to increase survival in locally advanced pancreatic cancer in the body and tail: a retrospective study
-
Severe neurodevelopmental disorder caused by an MEF2C nonsense mutation
-
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
-
Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy
-
Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study.
-
Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
DDIT4 Facilitates Lymph Node Metastasis via the Activation of NF-κB Pathway and Epithelial-Mesenchymal Transition
-
Optimized radiotherapy treatment strategy for early glottic carcinoma
-
Association of Local Intrapulmonary Production of Antibodies Specific to Donor Major Histocompatibility Complex Class I With the Progression of Chronic Rejection of Lung Allografts
-
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer
-
セツキシマブ併用放射線治療中にニューモシスチス肺炎を発症し,診断に苦慮した1例
-
Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation
-
Gut bacteria identified in colorectal cancer patients promote tumourigenesis via butyrate secretion
-
Expressions of ezrin, ERK, STAT3, and AKT in tongue cancer and association with tumor characteristics and patient survival.
-
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma : prediction of early recurrence based on genome-wide DNA methylation profiling (本文)
-
Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
-
Studies on Cytotoxic Effects of Tumor Necrosis Factor-Related Apoptosis Inducing Ligand (TRAIL) to Canine Cell Lines Derived from Hemangiosarcoma and Mammary Epithelial Tumor
-
Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer
-
Combination therapy of capecitabine, irinotecan, oxaliplatin, and bevacizumab as a first‐line treatment for metastatic colorectal cancer : Safety lead‐in results from the QUATTRO-II study
-
Characterization of the Anticancer Activities of Some Natural and Synthetic Compounds: Molecular Targets and Mechanism
-
Endoscopy-focused primary, secondary and tertiary prevention of colorectal cancer
-
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
-
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)
-
Research for elucidation of immune evasion mechanisms and development of a novel immunotherapy for cancer in dogs [an abstract of entire text]
-
Elderly patient with 5q spinal muscular atrophy type 4 markedly improved by Nusinersen
-
A case of systemic lupus erythematosus/systemic sclerosis overlap syndrome successfully treated with belimumab
-
Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer (本文)
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer.
-
A risk stratification model based on four novel biomarkers predicts prognosis for patients with renal cell carcinoma.
-
Morphea in a Crohn's disease patient undergoing ustekinumab treatment
-
Osteoprotegerin Prevents Intracranial Aneurysm Progression by Promoting Collagen Biosynthesis and Vascular Smooth Muscle Cell Proliferation
-
Relationship between Physical Activity and Health-related Quality of Life in Hospitalized and Terminally Ill Cancer Patients
-
Low RAI2 expression is a marker of poor prognosis in breast cancer
-
P2Y12 inhibitor monotherapy after complex percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials
-
Simultaneous hyperthermia-chemotherapy effect by arterial injection of Fe(Salen) for femur tumor
-
Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy
-
Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling.
-
Programmed death ligand-1 expression and occult lymph node metastasis in non-small cell lung cancer